Abstract
Mycobacterium abscessus disease is particularly challenging to treat, given the intrinsic drug resistance of this species and the limited data on which recommendations are based, resulting in a greater reliance on expert opinion. We address several commonly encountered questions and management considerations regarding pulmonary Mycobacterium abscessus disease, including the role of subspecies identification, diagnostic criteria for determining disease, interpretation of drug susceptibility test results, approach to therapy including the need for parenteral antibiotics and the role for new and repurposed drugs, and the use of adjunctive strategies such as airway clearance and surgical resection.
Original language | English (US) |
---|---|
Article number | ofz221 |
Journal | Open Forum Infectious Diseases |
Volume | 6 |
Issue number | 7 |
DOIs | |
State | Published - Jul 1 2019 |
Keywords
- bronchiectasis
- drug resistance
- lung disease
- mycobacterium abscessus
- non-tuberculous mycobacteria
ASJC Scopus subject areas
- Infectious Diseases
- Oncology